CTC
CVRS

Central Trust Company’s CORINDUS VASCULAR ROBOTICS, INC CVRS Stock Holding History

Central Trust Company’s Portfolio CVRS Stock Details CVRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-5,000
Closed -$7K – 1364
2018
Q1 		$7K Buy
+5,000
New +$5.8K ﹤0.01% 1086

Other funds holding CVRS

HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
HEC
Hudson Executive Capital New York $151M AUM 60.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
PVAM
Pacific View Asset Management San Francisco, California $20.8M AUM 20.08% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

Central Trust Company's CVRS Position: Q2 2018 in Review

Central Trust Company sold out of CORINDUS VASCULAR ROBOTICS, INC (CVRS) in Q2 2018, closing a stake of 5,000 shares — an estimated $7K sold.

Central Trust Company first reported a position in CVRS in Q1 2018 and held it in 1 quarter. The position peaked at $7K in Q1 2018. 53 funds tracked by Wall St. Rank hold CVRS as of Q2 2018.

  • Central Trust Company reported no remaining CORINDUS VASCULAR ROBOTICS, INC position as of Q2 2018 after selling out during the quarter.
  • Central Trust Company sold 5,000 CORINDUS VASCULAR ROBOTICS, INC shares in Q2 2018, an estimated $7K.
  • Central Trust Company first reported a position in CORINDUS VASCULAR ROBOTICS, INC in Q1 2018 and held it in 1 quarter.
  • Central Trust Company's CORINDUS VASCULAR ROBOTICS, INC position peaked at $7K in Q1 2018.
  • 53 funds tracked by Wall St. Rank held CORINDUS VASCULAR ROBOTICS, INC as of Q2 2018.

Based on Central Trust Company's 13F filing for Q2 2018, filed 9 Jul 2018.